sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Oncology Companion Diagnostics Market Scope And Analysis

  • Report Code : TIPRE00022282
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Oncology Companion Diagnostics Market Scope and Analysis by 2031

Buy Now

Oncology Companion Diagnostics Market Report Oncology Companion Diagnostics Market Size and Share Oncology Companion Diagnostics Market Scope and Analysis

Oncology Companion Diagnostics Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) XX%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Product
  • Instrument
  • Consumable
  • Software
By Technology
  • Polymerase Chain Reaction
  • Next-Generation Sequencing
  • Immunohistochemistry
  • In Situ Hybridization/Fluorescence in Situ Hybridization
  • Other Technologies
By Disease Type
  • Breast Cancer
  • Non-Small Cell Lung Cancer
  • Colorectal Cancer
  • Leukemia
  • Melanoma
  • Prostate Cancer
By End User
  • Hospital
  • Pathology/Diagnostic Laboratory
  • Academic Medical Center
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Qiagen
  • Illumina
  • F Hoffmann La Roche Ltd
  • Thermo Fisher Scientific Inc
  • Agilent Technologies Inc
  • Arup Laboratories
  • Abbott
  • Myriad Genetics Inc
  • Biom rieux SA